Mid-term Follow-Up Results of Cryopreserved Valved Conduit in RVOT Reconstruction.
- Author:
Yun Hee CHANG
1
;
Pyo Won PARK
;
Tae Gook JUN
;
Ho Ki MIN
;
Il Yong HAN
;
Ki Ick SUNG
;
Young Tak LEE
;
Kay Hyun PARK
Author Information
1. Department of Thoracic and Cardiovascular Surgery, Samsung Seoul Hospital, Sungkyukwan University School of Medicine, Korea. pwpark@smc.samsung.co.kr
- Publication Type:Original Article
- Keywords:
Cryopreservation;
Transplantation, homologous;
Conduits;
Ventricular outflow tract obstruction, right
- MeSH:
Allografts;
Child;
Constriction, Pathologic;
Cryopreservation;
Diagnosis;
Dilatation;
Follow-Up Studies*;
Heart Septal Defects, Ventricular;
Heart Ventricles;
Humans;
Infant;
Pulmonary Artery;
Pulmonary Atresia;
Pulmonary Valve Insufficiency;
Pulmonary Valve Stenosis;
Reoperation;
Transplantation, Homologous;
Transplants;
Truncus Arteriosus
- From:The Korean Journal of Thoracic and Cardiovascular Surgery
2003;36(6):384-390
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: Since Ross and Sormeville first reported the use of aortic homograft valve for correction of pulmonary atresia in 1966, homograft valves are widely used in the repair of congenital anomalies as conduits between the pulmonary ventricle and pulmonary arteries. On the basis of these results, we have used it actively. In this report, we describe our experience with the use of cryopreserved valved homograft conduits for infants and children requiring right ventricle to pulmonary artery connection in various congenital cardiac anomalies. MATERIAL AND METHOD: Between January,1996 and December 2001, 27 infants or children with a median age of 16 months(range 9days to 18years) underwent repair of RVOTO using homograft valved conduit by two surgeons. We studied 22 patients who have been followed up at least more than one year. The diagnosis at operation included pulmonary atresia with ventricular septal defect (n=13), truncus arteriosus (n=3), TGA or corrected TGA with RVOTO (n=6). Homograft valved conduits varied in size from 15 to 26 mm (mean, 183.82 mm). The follow-up period ranged from 12 to 80.4 months (median, 48.4 months). RESULT: There was no re-operation due to graft failure itself. However, early progressive pulmonary homograft valve insufficiency developed in one patient, that was caused by dilatation secondary to the presence of residual distal pulmonary artery stenosis and hypoplasia after repair of pulmonary atresia with ventricular septal defect. This patient was required reoperation (conduit replacement). During follow-up period, there were significant pulmonary stenosis in one, and pulmonary regurgitation more than moderate degree in 3. And there were mild calcifications at distal anastomotic site in 2 patients. All the calcified homografts were aortic in origin. CONCLUSION: We observed that cryopreserved homograft conduits used in infant and children functioned satisfactorily in the pulmonic position at mid-term follow-up. To enhance the homograft function, ongoing investigation is required to re-establish the optimal strategy for the harvest, preservation and the use of it.
